Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/08/035629
CTRI/2021/08/035629
Not yet recruiting
Phase 2

Therapeutic Efficacy of Eye Drops prepared by contents ofKatakadirasanjan in Visual Display Terminal Vision Syndrome A Clinical Study

Rishikul Campus Uttarakhand Ayurveda Uviversity0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: H538- Other visual disturbances

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: H538- Other visual disturbances
Sponsor
Rishikul Campus Uttarakhand Ayurveda Uviversity
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Rishikul Campus Uttarakhand Ayurveda Uviversity

Eligibility Criteria

Inclusion Criteria

  • •Patients between 18 to 40 years of age.
  • •2\. Computer users complaining of symptoms like eye strain, blurred vision, headache,
  • •redness, burning sensation, irritated dry eyes, slow refocusing and muscle fatigue.
  • •3\. Patients having minimum three symptoms of CVS.
  • •4\. Patients using computers for minimum 2 to 3 hrs/day and for at least 1 year
  • •continuously.

Exclusion Criteria

  • •Patients of age below 18 years or above 40 years.
  • •2\. Patients not willing to register.
  • •3\. Known cases of any systemic or metabolic disorders.
  • •4\. Case of chronic or acute infections of eye.
  • •5\. Patients having any fundus/retinal pathology like Optic atrophy, Retinal disorder,
  • •Papilloedema, etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Early Phase 1
sing exosome to treat severe dry eyesSevere dry eye.Dry eye syndrome of unspecified lacrimal glandH04.129
IRCT20170211032503N2Vision health research center30
Active, not recruiting
Not Applicable
Effect of video feedback on eye drop instillation technique in glaucoma patients
KCT0008090Jeonbuk National University Hospital76
Completed
Phase 3
Effect of eye drops for dry eye, glaucoma and cataract surgery using DEQS (Dry Eye Related Quality of Life Score)Dry eye, Glaucoma, and Cataract (Cataract surgery)
JPRN-UMIN000017667Sapporo Tokushukai Hospital100
Unknown
Not Applicable
Clinical study about the ocular administration of the anti-VEGF antibody for the retinopathy of prematurity
JPRN-UMIN000025361ara Medical University20
Completed
Phase 2
Comparison of effect of topical ophthalmic drop tacrolimus 1% versus topical ophthalmic drop dexamethasone 1% in the treatment of patients with shield ulcer
IRCT2016110630746N1Vice chancellor for research, Zahedan University of Medical Sciences20